Title : Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.

Pub. Date : 2020 Jun

PMID : 32171145






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway. Naltrexone B cell leukemia/lymphoma 2 Mus musculus